A prospective randomisd open label study to determine the effects of intravenous iron administration on markers of acute kidney injury in chronic kidney disease (CKD)
Latest Information Update: 09 Feb 2023
At a glance
- Drugs Ferric derisomaltose (Primary) ; Iron dextran (Primary) ; Iron sucrose (Primary)
- Indications Iron deficiency anaemia
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms IRON-CKD
Most Recent Events
- 27 Jul 2020 Status changed from recruiting to completed.
- 26 Aug 2019 New trial record